Awarded Contractocds-b5fd17-c5f1ad7d-fcac-4ac7-bdd9-f6fe1f150616

NHS National Generics Pharmaceuticals - Dasatinib and Paliperidone Injection

Invitation to offer for NHS National Generic Pharmaceuticals - Dasatinib and Paliperidone Injection Offer reference number: CM/PHG/22/5694 FIND A TENDER (FTS) - 2023/S 000-001392 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 21 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: CM/PHG/22/5694/00 - Dasatinib CESW 01/05/2023...

Buyer

NHS England

Value

£27,009,807

Published

27 Apr 2023

Closes

21 Feb 2023

Procurement details

Source

Contracts Finder

Region

London

Procurement method

Open

Category

Goods

Contract starts

30 Apr 2023

Contract ends

31 Jan 2025

CPV classifications

33600000

Pharmaceutical products

Lots

Lot default NHS National Generics Pharmaceuticals - Dasatinib and Paliperidone Injection

£27,009,807

Invitation to offer for NHS National Generic Pharmaceuticals - Dasatinib and Paliperidone Injection Offer reference number: CM/PHG/22/5694 FIND A TENDER (FTS) - 2023/S 000-001392 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 21 months with an option or options to extend (at the Authority's discretion)...

Delivery: East Midlands · United Kingdom, East of England · United Kingdom, Guernsey, Isle of Man, Jersey, London · United Kingdom

Awarded contract notice on Contracts Finder

27 Apr 2023

Awarded contract notice on Contracts Finder

Award notice · Web page

CM_PHG_22_5694_00 Transparency Award Schedules

Not provided

CM_PHG_22_5694_00 Transparency Award Schedules

PDF

CM_PHG_22_5694_01 Transparency Award Schedule

Not provided

CM_PHG_22_5694_01 Transparency Award Schedule

PDF

Contains public sector information licensed under the Open Government Licence v3.0.